Weldon Biotech (India) Private Limited - Due diligence report

A 360° intelligence report on Weldon Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals…

2004-01-22 Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
WB Weldon Biotech (India) Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Weldon Biotech — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Weldon Biotech is assessed as Low Risk with a Trust Score of 78/100. Weldon Biotech is an active private limited indian non-government company incorporated in 2004, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 01 Aug 2026 from the latest processed filings. Weldon Biotech (India) Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
63/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 6 open (23.72 cr) · 6 satisfied (5.60 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others8 48.0 cr
Ecl Finance Limited1 48.0 cr
Deutsche Bank Ag1 48.0 cr
Bank Of Maharashtra1 48.0 cr
Canara Bank1 48.0 cr
Compliance Score: 63/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: EPFO.
  • Litigation present in 1 court forum(s).
  • 3 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUNITA CHAUDHARY 01234567 Director 01/04/2018 6 yrs Approved
AAKASH CHOUDHARY 01234567 Director 01/04/2018 6 yrs Approved
ANIL KUMAR CHOUDHARY 01234567 Director 01/04/2018 6 yrs Approved
SAGAR CHOUDHARY 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
6 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 6 open charge(s) of 23.72 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
08 May 2025
Charge created
Others - 3.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Nov 2024
Charge created
Others - 1.00 cr
01 Oct 2024
Charge created
Others - 5.00 cr
03 Sep 2024
Charge created
Others - 1.50 cr
19 Jan 2024
Charge created
Others - 3.22 cr
30 Jun 2022
Charge created
Others - 10.00 cr
22 Jun 2022
Charge satisfied
Others
Charge satisfied
Deutsche Bank Ag
20 Apr 2022
Charge satisfied
Bank Of Maharashtra
27 Apr 2021
Charge created
Others - 13.88 Lakh
17 Aug 2020
Director appointed
AAKASH CHOUDHARY (Director)
22 Feb 2019
Charge satisfied
Canara Bank
30 Jan 2019
Charge satisfied
Ecl Finance Limited
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sanchay Vanijya Rasayan Private Limited U47219DL1982PTC014013 Delhi, Delhi, India
Abhayanand Steel Private Limited U13100GA2005PTC004111 Panaji, Goa, India
Power Centre U46510TN1972PTC006137 Chennai City Corporation, Tamil Nadu, India
Kameshwar Alloys & Steels Private Limited U27100WB2008PTC128399 Kolkata, West Bengal, India
Asa Decofur Private Limited U51909WB2011PTC167229 Kolkata, West Bengal, India
Purbanchal Trading Company (Calcutta)Private Limited U51505WB1997PTC084355 Kolkata, West Bengal, India
Oceanic Developers Pvt Ltd U45202WB1994PTC064709 Kolkata, West Bengal, India
Royal Spices U74120UP2011PTC044871 Chandauli, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Weldon Biotech before audits and certifications: compliance score 63/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Weldon Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Weldon Biotech - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Weldon Biotech pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Weldon Biotech - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Weldon Biotech an active company?

Weldon Biotech has MCA status “Active” with a compliance score of 63/100 (Moderate).

Is Weldon Biotech financially healthy?

Weldon Biotech has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Weldon Biotech?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Weldon Biotech?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Weldon Biotech have loans or charges against its assets?

6 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.

Is Weldon Biotech up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 63/100 (Moderate).

Is it risky to lend to Weldon Biotech?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.